Breztri is an inhaled triple-combination therapy approved for the treatment of chronic obstructive pulmonary disease
This recertification of Company's OECD GLP is testimony to company's unwavering commitment to maintain international quality standards at the facility
Alembic Pharmaceuticals commissions new facility at Pithampur
The transaction structured as share swap, is valued at ~Rs. 849 crore, with no cash outflow
The Board has also approved plans to invest approximately Rs. 500 crores including cost of land in developing a state-of-the-art, 400-bed super specialty hospital
ekincare has raised a total funding of $22M since 2015 till date
The inspection concluded with 6 observations and none of them were related to Data Integrity
This approval authorizes the company to export Ibuprofen to the Chinese markets
Investment demonstrates confidence in America’s commitment to science and innovation
Delivers robust earnings performance, successfully navigating a dynamic environment
Subscribe To Our Newsletter & Stay Updated
